4.7 Article

High-sensitive electrochemical sensor for determination of Norfloxacin and its metabolism using MWCNT-CPE/pRGO-ANSA/Au

期刊

SENSORS AND ACTUATORS B-CHEMICAL
卷 257, 期 -, 页码 1065-1075

出版社

ELSEVIER SCIENCE SA
DOI: 10.1016/j.snb.2017.11.052

关键词

Electrochemical sensor; Norfloxacin; Gold nanoparticles; Graphene oxide; Multi-walled carbon nanotubes; Metabolism

资金

  1. National Key Research & Development Program of China [2016YFB0401502]
  2. National Natural Science Foundation of China [61574065]
  3. Science and Technology Planning Project of Guangdong Province [2016B090906004]
  4. PCSIRT Project [IRT_17R40]
  5. National 111 Project
  6. MOE International Laboratory for Optical Information Technologies
  7. Guangdong Innovative Research Team Program [2011D039]

向作者/读者索取更多资源

In this work, a high-sensitive electrochemical sensor of Norfloxacin (NFX) has been developed using a composite electrode of MWCNT-CPE/pRGO-ANSA/Au. MWCNT-CPE is the multi-walled carbon nanotubes (MWCNT) - carbon paste electrode (CPE). pRGO-ANSA means the partially reduced graphene oxide (pRGO) - 6-aminonaphthalene-2-sulphonic acid (ANSA) hybrid nanomaterials. Au represents gold nanoparticles. The electrochemical sensing of NFX was investigated by cyclic voltammetry (CV), linear sweep voltammetry (LSV) and differential pulse voltammetry (DPV). Experimental results show that the combination of MWCNT-CPE/pRGO-ANSA/Au offers high electrical conductivity, large surface area and excellent electrocatalytic activity, being beneficial for electrochemical sensing performance. The calibration curves of NFX exhibit linear response in the NFX concentration range of 0.03-1.0 and 1.0-50.0 mu M, with the limit of detection (LOD) of 0.016 mu M (S/N = 3). The fabricated sensors were successfully applied for detecting the presence of NFX in pharmaceutical formulations and rat plasma samples. The measured results were comparable with those obtained using ultrahigh performance liquid chromatography (UHPLC), indicating its high potential for applications in pharmaceutical analysis and clinical therapeutic drug monitoring. (C) 2017 Elsevier B.V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据